Six years ago this month, New York declared a state of emergency due to covid-19. With the pandemic, the use of mRNA technology for vaccines became more mainstream. At ...

The University of Kent says the vaccination queue has "closed" for the day, but urged students to return for the jab tomorrow.

A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell engager." This type of immunotherapy ignites our own ...

For most patients, the loss faded within weeks or months. But for a smaller group, taste never fully returned. Even years after infection, certain flavors remain muted or completely absent.

Researchers have devised a new tool for discerning between naturally occurring viral outbreaks and those resulting from lab ...

Cas9, Transcription Activator-Like Effector Nucleases (TALENs), and Zinc-Finger nucleases (ZFNs) have demonstrated great utility, primarily for genetic knock-out applications, none have been adopted ...

“Imagine getting a nasal spray in the fall months that protects you from all respiratory viruses, including COVID-19, influenza, respiratory syncytial virus, and the common cold, as well as bacterial ...

A new study provides the first direct biological evidence explaining why some people continue to experience taste loss long after recovering from COVID-19.

Some individuals have experienced a loss of taste long after a COVID-19 infection has subsided. Researchers from the Swedish University of Agricultural Sciences, Uppsala University and the University ...

New CDC report reveals that flu season is far from over. While flu A cases are dwindling, flu B and COVID-19 cases are on the rise nationwide. Here’s where to find the best home tests for early ...

Anthony Wong is a Post-Doctoral Fellow at the University of British Columbia that receives funding from Canadian Institutes of Health Research (CIHR), Health Research BC, and Canadian Biomedical ...

Contributed by Rafi Ahmed; received January 15, 2024; accepted July 2, 2025; reviewed by Stephen C. Jameson and Robert Seder CD45 isoforms are used to distinguish between naïve (CD45RA) and effector T ...